Acetic Acid

Acetic Acid

SCHEMBL4421985

CC(=O)O.CCCc1cc(C(CC)(CC)c2ccc(S(N)(=O)=O)s2)ccc1OCC(O)C(C)(C)C

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 9/20 0.46
HDAC3 O15379 5/20 0.46
HDAC1 Q13547 1/20 0.42
VDR P11473 9/20 0.41
AR P10275 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid Methyl Ester SCHEMBL3389812 0.95 HDAC6 (0.47) HDAC6HDAC3HDAC1VDRAR
Acetic Acid SCHEMBL3388905 0.94 HDAC6 (0.46) HDAC6HDAC3HDAC1VDRAR
Acetic Acid SCHEMBL3391257 0.89 HDAC6 (0.55) HDAC6HDAC3HDAC1VDRAR
Acetic Acid Methyl Ester SCHEMBL3389823 0.89 HDAC6 (0.47) HDAC6HDAC3HDAC1VDRAR
SCHEMBL4421979 0.85 HDAC6 (0.46) HDAC6HDAC3HDAC1VDRAR
Acetic Acid Methyl Ester SCHEMBL3392982 0.84 HDAC6 (0.56) HDAC6HDAC3HDAC1VDRAR
SCHEMBL3391026 0.83 HDAC6 (0.50) HDAC6HDAC3HDAC1VDRAR
SCHEMBL3389811 0.83 HDAC6 (0.46) HDAC6HDAC3HDAC1VDRAR
SCHEMBL3392738 0.80 HDAC6 (0.51) HDAC6HDAC3HDAC1VDRAR
SCHEMBL13672905 0.80 HDAC6 (0.46) HDAC6HDAC3HDAC1VDRAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601850-B2 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis ELI LILLY AND COMPANY (US) 2009-10-13 US disclosed
EP-1511740-B1 PHENYL-THIOPHENE TYPE VITAMIN D RECEPTOR MODULATORS LILLY CO ELI (US) 2009-07-08 EP disclosed
US-20060287536-A1 Phenyl-thiophene type vitamin d receptor modulators ELI LILLY AND COMPANY 2006-12-21 US disclosed
EP-1511740-A1 PHENYL-THIOPHENE TYPE VITAMIN D RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-03-09 EP disclosed
WO-2003101978-A1 PHENYL-THIOPHENE TYPE VITAMIN D RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287536-A1 Phenyl-thiophene type vitamin d receptor modulators VDR, CYP2R1, CYP24A1 HDAC6 4626/4885HDAC3 2229/4885HDAC1 2621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.